Be happy, use TAPI

With ever-increasing and stiffer regulatory barriers for high-quality active pharmaceutical ingredients (API), one of the largest API producers in the world offers peace of mind for purchasing. Years of specialisation combined with a global presence and high production standards ensure superior quality while keeping prices affordable.

Teva Active Pharmaceutical Ingredients (TAPI) is a business unit of Teva Pharmaceutical Industries Limited. With $1.9 billion in annual API sales, employing over 4,400 professionals worldwide and 20 production facilities, TAPI offers a rich portfolio of almost 300 active pharmaceutical ingredients.

TAPI’s financial strength, global production capacity and long-term commitment to the pharmaceutical industry are key ingredients of success. All of the company’s production plants are regularly inspected by the US Food and Drug Administration (FDA) and other authorities as well as by its customers. During 2008, the FDA performed ten successful inspections at TAPI’s production plants worldwide.

With more than 70 years of experience, TAPI has become a leading international supplier of active pharmaceutical ingredients to generic and innovative companies. Decades of specialisation in API production gives TAPI unparalleled expertise. TAPI offers professional services that combine the science of chemistry with the company’s vast experience in process development – yielding a synergy of efficient, highquality production.

Specialised expertise
Research and development (R&D) is performed by a dedicated team of over 600 top scientists. This diverse team is located in ten development centres throughout the world, specialising in the fields of:

• chemical synthesis
• fermentation
• enzymatic processes
• high potency
• plant extract
• synthetic peptides
• vitamin D derivatives
• analytical and solid state R&D.

TAPI customers benefit from the knowledge and abilities of the company’s top scientists – many of whom are renowned for their expertise in developing manufacturing processes and technologies, as well as their experience in applying this expertise to synthesis.

Decades of experience in research and implementation of production techniques have given TAPI distinctive advantages that clients can leverage to benefit their bottom line, without risking a commitment to quality.

Be happy, use TAPI
Striving for the highest possible customer satisfaction worldwide, TAPI has implemented a crossorganisation supply chain tracing model to improve supply performance. In the last two years this has dramatically improved supply performance, leading to shortened delivery times, high reliability and outstanding customer satisfaction.
It is this combination of superior customer service and fast delivery times, together with experience and high-quality products, that creates a win-win situation that brings out the best in your API experience.

Company profile

TAPI enjoys an international presence in the healthcare industry. With its headquarters based in Israel, 80% of its sales are generated in Europe and North America. It has facilities in Israel, North America, Latin America and Europe. TAPI is a business unit of Teva Pharmaceutical Industries Limited.

For more information, visit: www.tapi.com.